NEWS: (8) Film Acquisitions (8) New "Direct-To-Video"

New Post Public Reply Private Reply Replies (0) Message Board
speckulater

NEWS: (8) Film Acquisitions

(8) New "Direct-To-Video" Thriller Genre Film Acquisitions


Hannover House Builds on Core Strengths with Sci-Fi and Horror Film Acquisitions 


LOS ANGELES, CA, 6/20/2013 7:45:00 AM - 

Hannover House, Inc. (HHSE) has announced an immediate increase in the company's output of film releases to the home video and video-on-demand markets, with the greatest level of new activity occurring with science-fiction, thrillers and horror titles. Eight new releases will begin hitting the retail home video shelves as early as October, fueled by new corporate funding from TCA Global and ongoing retailer support generated from consistent sales success with prior Hannover House releases. 

Recently released sci-fi and horror DVD titles from Hannover House include "Zombie Warz", "Humans vs. Zombies", "Boggy Creek" and "Patient Zero," with major retailer support that has included Wal-Mart, Redbox, Netflix and Blockbuster, among many other national retailers and independent video dealers. The newly acquired slate of films is expected to fit nicely into the current programming plans for the company's key accounts. 

"Consumers love science-fiction and horror titles," said Eric Parkinson, Hannover House C.E.O. "Thrillers are widely popular, retail-friendly and a very profitable category for the company to grow. From a standpoint of doing-more-of-what-works-best for Hannover House, an expansion of our release activities for sci-fi, horror and thrillers makes a lot of sense." 

Recently acquired sci-fi, horror and thriller genre' titles for Hannover House include: 



TO.GET.HER -
From director Erica Dunton, winner of the Best of Next Audience Award at the 2011 Sundance Film Festival, this suspense-thriller details the horrifying outcome when a dream beach vacation for a group of teenaged-girlfriends descends into a murderous nightmare. Licensed from Film Sales Company, New York.


THE HONEYMOON -
An impressive debut feature from director Rob Rowatt, which chronicles how a romantic, camping getaway turns into a honeymoon from hell, when the newlyweds witness a murder and now must be eliminated. Licensed from Lakefield Pictures, Canada. 


AMITYVILLE ASYLUM -
Director Andrew Jones presents a terrifying look inside the Asylum for the Insane in Amityville, New York, with the dark secrets of the haunted facility finally revealed. Licensed from Northbank Entertainment, United Kingdom.


INGLODA: THE POSSESSION WITHIN -
A powerful, new thriller from director Brian Targett and producer Everett Burgan that explores the fine-line between insanity and full-scale demonic possession. Licensed from On-Ride Entertainment, LLC, Philadelphia. 


FRANKENSTEIN: DAY OF THE BEAST -
Director Ricardo Islas presents a terrifying new twist on the classic Frankenstein monster. Victor Frankenstein's plans to wed the lovely Elizabeth are challenged when the beast begins a brutal attack. Licensed from Alpha Studios, Chicago.


VALLEY OF THE WITCH - (In Production) -
A gothic thriller shot in Wales that combines suspense elements from "The Others", "Rosemary's Baby" and "The Wicker Man" into an elegant and thrilling contemporary classic. Licensed from Valley of the Witch, Ltd., London. 


MIDNIGHT HORROR SHOW - (In Production) -
Horror and camp combine in this offbeat thriller about the traveling carnival show in rural England, with a horrific habit of killing off members of its audience. Licensed from Midnight Horror, Ltd., London.


THE COFFIN (aka "Buried Alive") -
Director Kevin Clark's suspenseful tale of a man trapped in a coffin, with only an hour's worth of air and cell-phone battery left to solve the mystery that can save his life. Licensed from Fubot Pictures, San Francisco.




In addition to these eight genre releases, Hannover House has also recently acquired six additional titles including two urban-action films, two mainstream action films, and two dramatic features. These new acquisitions have benefitted from Hannover's recently announced financing agreement with TCA Global, which facilitates funding for new acquisitions, marketing, manufacturing and releasing costs. Ten additional titles (previously acquired but pending release) round out the company's slate of new titles scheduled from October, 2013 through March, 2014. 

Hannover House is a full-service entertainment distribution company, with activities in all major media for filmed-entertainment (including theatrical, home video, video-on-demand and television). The company was founded twenty years ago in 1993 as a book publisher, with DVD products added in 2002 and theatrical activities added in 2008. The company's primary office is located in Northwest Arkansas, as a strategic location near Wal-Mart Stores, Inc., the largest purchaser of entertainment products in the world (with a USA market share of more than 50% of all studio DVD sales, according to Home Media Magazine). 

The company has recently scaled back its activities with mid-level, theatrically released titles due to a financial analysis which showed that a greater return-on-investment was being generated from a "direct-to-video" release model. Except for three "tentpole" major releases each year, the theatrical campaigns for upcoming Hannover House titles will likely be limited to key markets or specific screen-counts as may be needed for ancillary contract requirements. 

In the book publishing field, Hannover House has three print edition new releases set for 2013, and five e-book format releases. The new print edition books are "One of the Lucky Ones" by Brenda Hancock (the authorized biography of her mother, Nicole Holland, who as a young girl in France during World War II, fought in the French Resistance while disguising her Jewish heritage); "Blind Vision" from best-selling author Vivian Kaplan (based on the true story of a Jewish exodus out of Spain and western Europe, and subsequent adoption of Christianity for societal survival); and "Sable Shore" a debut novel from James Danielson (about a man's mid-life crisis slamming head-on with a murder mystery twist). Previous Hannover House book releases have generated substantial sales and acclaim, including a #1 charting national best-seller (Barr McClellan's "Blood, Money & Power: How LBJ Killed JFK") and the critically-praised, supernatural suspense-thriller, "Quietus" by Vivian Schilling. 

Shares in Hannover House stock are traded on the OTC Markets under the symbol: HHSE.


http://news.yahoo.com/hannover-house-builds-c...00453.html

http://www.otcmarkets.com/stock/HHSE/news

.

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on CDW's Market Position and P/E Ratio Analysis

Updated Category News Views 123

Analyzing CDW's Current Market Performance CDW Inc.'s current stock price stands at $164.29, reflecting a notable increase of 2.59% during the ongoing market session. Despite this uptick, shareholders might be concerned as the stock has experienced a decline of 6.53% over the past month and a more significant drop of 24.18% over the last year. With these figures, it...

Continue Reading
What the Recent Earnings Report Means for FactSet Research

Updated Category News Views 135

FactSet Research Exceeds Expectations in Q1 Performance FactSet Research Systems Inc. (NYSE: FDS) has reported first-quarter results that exceeded analyst expectations, showcasing strong performance in a competitive financial market. The company achieved first-quarter sales totaling $607.6 million, surpassing the anticipated $600.5 million, which reflects a commendable...

Continue Reading
Dime Community Bancshares Unveils Executive Transition Plans

Updated Category News Views 180

Dime Community Bancshares Executive Changes Dime Community Bancshares, Inc. (NASDAQ: DCOM) recently announced significant changes in its leadership team as part of a strategic succession plan. This initiative reflects the company’s commitment to fostering a robust executive structure and enhancing its operational growth. Leadership Transition Details As Dime prepares...

Continue Reading
Hygiene Products Industry on Track to Reach $14.62 Billion

Updated Category News Views 112

Overview of the Antiseptic Products Market The global antiseptic products market is projected to experience remarkable growth, reaching an estimated value of USD 10.85 billion in 2025, and anticipated to climb to USD 14.62 billion by 2032. This represents a compound annual growth rate (CAGR) of 4.35% during the period. As health-conscious consumers become increasingly...

Continue Reading
China's Enduring Commitment to Global Peace and Prosperity

Updated Category News Views 91

China's Historical Role in the UN The United Nations (UN) stands as a testament to humanity's resolve for peace, shaped significantly by historical events like the World Anti-Fascist War. This war saw the Allies, including China, rally against the Axis powers, fostering a crucial international alliance. Founded as a result of collective victories, the UN embodies the...

Continue Reading